首页> 外国专利> DIPEPTIDE DERIVATIVE AND MEDICINE FOR PREVENTING AND IMPROVING OSTEOPATHY, CONTAINING THE SAME COMPOUND AS ACTIVE COMPONENT

DIPEPTIDE DERIVATIVE AND MEDICINE FOR PREVENTING AND IMPROVING OSTEOPATHY, CONTAINING THE SAME COMPOUND AS ACTIVE COMPONENT

机译:二肽衍生物和药物,用于预防和改善骨质疏松症,包含与活性成分相同的化合物

摘要

PURPOSE:To provide the subject new compounds showing an inhibitory effect on depression of Ca-concentration or collagen fiber content in bone and useful as a medicine for preventing and improving bone-absorption diseases such as malignant hypercalcemia, bone Paget's disease and osteoporosis. CONSTITUTION:Compounds of formula I (R is aliphatic acyl or benzyloxycarbonyl which may be respectively substituted with halogen; R2 is lower alkyl or aralkyl; R3 is lower alkyl, methylthioethyl, etc.; R4 is aliphatic acyl, hydroxyiminomethyl, etc.) e.g. N-benzyloxy-carbonyl-L-leucin-(1-ethoxalyl) pentylamide. The compound of formula I, in the case of R = benzyloxycarbonyl and R4=-CO-COOR5 (R5 is lower alkyl), can be obtained by saponifying a compound of formula II (R6 is R5) in an aqueous alkaline solution, subsequently converting the resultant compound into its anhydride, then reacting the anhydride with methoxymethylamine and ethyl vinyl ether in order and subsequently carrying out ozone oxidation.
机译:目的:提供具有抑制骨中钙浓度降低或骨中胶原纤维含量抑制作用的新化合物,并用作预防和改善诸如恶性高钙血症,骨佩吉特氏病和骨质疏松症等骨吸收疾病的药物。组成:式I化合物(R为可分别被卤素取代的脂族酰基或苄氧羰基; R 2为低级烷基或芳烷基; R 3为低级烷基,甲硫基乙基等; R 4为脂族酰基,羟基亚氨基甲基等),例如N-苄氧基-羰基-L-亮氨酸-(1-乙氧基)戊酰胺。在R =苄氧羰基且R 4 = -CO-COOR 5(R 5为低级烷基)的情况下,式I的化合物可以通过将式II的化合物皂化而得到(R 6 > R 5)在碱性水溶液中,随后将所得化合物转化为其酸酐,然后使酸酐与甲氧基甲基胺和乙基乙烯基醚依次反应,随后进行臭氧氧化。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号